+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Transcatheter Aortic Valve Implantation (TAVI) - Medical Devices Pipeline Assessment, 2020

  • ID: 5189464
  • Report
  • October 2020
  • Region: Global
  • 138 pages
  • GlobalData

FEATURED COMPANIES

  • Aegis Surgical Limited
  • Clemson University
  • Edwards Lifesciences Corp
  • Mayo Clinic
  • RegenaGraft
  • Symetis SA
  • MORE
Summary

The publisher's Medical Devices sector report, “Transcatheter Aortic Valve Implantation (TAVI) - Medical Devices Pipeline Assessment, 2020“. Transcatheter Aortic Valve Implantation, also known as Transcatheter Aortic Valve Replacement (TAVR), is a minimally invasive procedure used to treat severe aortic valve stenosis by implanting a Transcatheter Heart Valve in a patient's diseased aortic valve.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Transcatheter Aortic Valve Implantation (TAVI) under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Transcatheter Aortic Valve Implantation (TAVI) and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to Buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Transcatheter Aortic Valve Implantation (TAVI) under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Aegis Surgical Limited
  • Clemson University
  • Edwards Lifesciences Corp
  • Mayo Clinic
  • RegenaGraft
  • Symetis SA
  • MORE
1 Table of Contents
1.1 List of Tables
1.2 List of Figures

2 Introduction
2.1 Transcatheter Aortic Valve Implantation (TAVI) Overview

3 Products under Development
3.1 Transcatheter Aortic Valve Implantation (TAVI) - Pipeline Products by Stage of Development
3.2 Transcatheter Aortic Valve Implantation (TAVI) - Pipeline Products by Territory
3.3 Transcatheter Aortic Valve Implantation (TAVI) - Pipeline Products by Regulatory Path
3.4 Transcatheter Aortic Valve Implantation (TAVI) - Pipeline Products by Estimated Approval Date
3.5 Transcatheter Aortic Valve Implantation (TAVI) - Ongoing Clinical Trials

4 Transcatheter Aortic Valve Implantation (TAVI) - Pipeline Products under Development by Companies
4.1 Transcatheter Aortic Valve Implantation (TAVI) Companies - Pipeline Products by Stage of Development
4.2 Transcatheter Aortic Valve Implantation (TAVI) - Pipeline Products by Stage of Development

5 Transcatheter Aortic Valve Implantation (TAVI) Companies and Product Overview
5.1 Aegis Surgical Limited Company Overview
5.1.1 Aegis Surgical Limited Pipeline Products & Ongoing Clinical Trials Overview
5.2 Anteris Technologies Ltd Company Overview
5.2.1 Anteris Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.3 AorTx, Inc. Company Overview
5.3.1 AorTx, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.4 Arbor Surgical Technologies, Inc. Company Overview
5.4.1 Arbor Surgical Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.5 Boston Scientific Corp Company Overview
5.5.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
5.6 Carena Healthcare Ltd Company Overview
5.6.1 Carena Healthcare Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.7 Clemson University Company Overview
5.7.1 Clemson University Pipeline Products & Ongoing Clinical Trials Overview
5.8 Colibri Heart Valve LLC Company Overview
5.8.1 Colibri Heart Valve LLC Pipeline Products & Ongoing Clinical Trials Overview
5.9 Daidalos Solutions BV Company Overview
5.9.1 Daidalos Solutions BV Pipeline Products & Ongoing Clinical Trials Overview
5.10 Direct Flow Medical Inc (Inactive) Company Overview
5.10.1 Direct Flow Medical Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.11 DSM Dyneema BV Company Overview
5.11.1 DSM Dyneema BV Pipeline Products & Ongoing Clinical Trials Overview
5.12 Dura LLC Company Overview
5.12.1 Dura LLC Pipeline Products & Ongoing Clinical Trials Overview
5.13 Edwards Lifesciences Corp Company Overview
5.13.1 Edwards Lifesciences Corp Pipeline Products & Ongoing Clinical Trials Overview
5.14 Foldax Inc Company Overview
5.14.1 Foldax Inc Pipeline Products & Ongoing Clinical Trials Overview
5.15 HLT, Inc. Company Overview
5.15.1 HLT, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.16 JC Medical, Inc. Company Overview
5.16.1 JC Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.17 JenaValve Technology GmbH Company Overview
5.17.1 JenaValve Technology GmbH Pipeline Products & Ongoing Clinical Trials Overview
5.18 Mayo Clinic Company Overview
5.18.1 Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview
5.19 Medtronic Plc Company Overview
5.19.1 Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview
5.20 MicroPort Scientific Corp Company Overview
5.20.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
5.21 NVT AG Company Overview
5.21.1 NVT AG Pipeline Products & Ongoing Clinical Trials Overview
5.22 Peijia Medical Ltd Company Overview
5.22.1 Peijia Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.23 PolyNova Cardiovascular Inc Company Overview
5.23.1 PolyNova Cardiovascular Inc Pipeline Products & Ongoing Clinical Trials Overview
5.24 RegenaGraft Company Overview
5.24.1 RegenaGraft Pipeline Products & Ongoing Clinical Trials Overview
5.25 ReValve Med Inc Company Overview
5.25.1 ReValve Med Inc Pipeline Products & Ongoing Clinical Trials Overview
5.26 SAS Cormove Company Overview
5.26.1 SAS Cormove Pipeline Products & Ongoing Clinical Trials Overview
5.27 St. Jude Medical LLC Company Overview
5.27.1 St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
5.28 Stony Brook University Company Overview
5.28.1 Stony Brook University Pipeline Products & Ongoing Clinical Trials Overview
5.29 Symetis SA Company Overview
5.29.1 Symetis SA Pipeline Products & Ongoing Clinical Trials Overview
5.30 The University of British Columbia Company Overview
5.30.1 The University of British Columbia Pipeline Products & Ongoing Clinical Trials Overview
5.31 Thubrikar Aortic Valve, Inc. Company Overview
5.31.1 Thubrikar Aortic Valve, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.32 University College London Company Overview
5.32.1 University College London Pipeline Products & Ongoing Clinical Trials Overview
5.33 University of California San Francisco Company Overview
5.33.1 University of California San Francisco Pipeline Products & Ongoing Clinical Trials Overview
5.34 University of Cambridge Company Overview
5.34.1 University of Cambridge Pipeline Products & Ongoing Clinical Trials Overview
5.35 University of Iowa Company Overview
5.35.1 University of Iowa Pipeline Products & Ongoing Clinical Trials Overview
5.36 Vascular Concepts Ltd Company Overview
5.36.1 Vascular Concepts Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.37 Venus MedTech Company Overview
5.37.1 Venus MedTech Pipeline Products & Ongoing Clinical Trials Overview
5.38 Xeltis AG Company Overview
5.38.1 Xeltis AG Pipeline Products & Ongoing Clinical Trials Overview

6 Transcatheter Aortic Valve Implantation (TAVI)- Recent Developments
6.1 Jun 24, 2020: Apollo Hospitals, Indore successfully performs Transcatheter Aortic Valve Replacement surgery on a nonagenarian patient.
6.2 May 19, 2020: Anti-calcification comparison study
6.3 Apr 14, 2020: BioCardia announces litigation financing in the case captioned Boston Scientific
6.4 Mar 28, 2020: Edwards pauses enrollments in pivotal mitral, tricuspid trials in response to hospitals' focus on COVID-19
6.5 Feb 24, 2020: 2020 Catalyst award winner Medtronic hires Chief Inclusion and Diversity Officer
6.6 Feb 24, 2020: 2020 Catalyst Award Winner Medtronic hires Chief Inclusion and Diversity Officer
6.7 Feb 18, 2020: Medtronic reports third quarter financial results 2020
6.8 Feb 17, 2020: Hershey Medical Center becomes first in region to offer latest Edwards Sapien heart valve device
6.9 Feb 05, 2020: Boston Scientific announces results for fourth quarter and full year 2019
6.10 Jan 22, 2020: First-in-human SAVR trial begins Q1 2020
6.11 Jan 14, 2020: Boston Scientific announces preliminary unaudited sales for the fourth quarter and full year 2019
6.12 Jan 09, 2020: JenaValve Transcatheter Aortic Valve Replacement (TAVR) System designated by FDA as breakthrough device
6.13 Dec 04, 2019: Lumeon and Medtronic partner to deliver new models of care in Europe
6.14 Nov 19, 2019: Medtronic reports second quarter financial results for the year 2019
6.15 Nov 18, 2019: MyVal transcatheter heart valve reports positive trial results

7 Appendix
7.1 Methodology
7.2 About the Publisher
7.3 Contact
7.4 Disclaimer

List of Tables
Table 1: Transcatheter Aortic Valve Implantation (TAVI) - Pipeline Products by Stage of Development
Table 2: Transcatheter Aortic Valve Implantation (TAVI) - Pipeline Products by Territory
Table 3: Transcatheter Aortic Valve Implantation (TAVI) - Pipeline Products by Regulatory Path
Table 4: Transcatheter Aortic Valve Implantation (TAVI) - Pipeline Products by Estimated Approval Date
Table 5: Transcatheter Aortic Valve Implantation (TAVI) - Ongoing Clinical Trials
Table 6: Transcatheter Aortic Valve Implantation (TAVI) Companies - Pipeline Products by Stage of Development
Table 7: Transcatheter Aortic Valve Implantation (TAVI) - Pipeline Products by Stage of Development
Table 8: Aegis Surgical Limited Pipeline Products & Ongoing Clinical Trials Overview
Table 9: pTAo-TAVR - Product Status
Table 10: pTAo-TAVR - Product Description
Table 11: Anteris Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 12: DurAVR Heart Valve - Product Status
Table 13: DurAVR Heart Valve - Product Description
Table 14: Anteris Technologies Ltd - Ongoing Clinical Trials Overview
Table 15: DurAVR Heart Valve - First in Human Surgical Implantation of Single Piece ADAPT Treated 3D ALR (Aortic Leaflet Repair), Feasibility and Clinical Safety Study
Table 16: AorTx, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 17: AorTx Valve - Product Status
Table 18: AorTx Valve - Product Description
Table 19: Arbor Surgical Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 20: Trilogy Aortic Valve System - Product Status
Table 21: Trilogy Aortic Valve System - Product Description
Table 22: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 23: Gen 4 Lotus Valve System - Product Status
Table 24: Gen 4 Lotus Valve System - Product Description
Table 25: Lotus Edge Sheath 15F - Product Status
Table 26: Lotus Edge Sheath 15F - Product Description
Table 27: LOTUS Edge Valve Expanded Sizes - Product Status
Table 28: LOTUS Edge Valve Expanded Sizes - Product Description
Table 29: LOTUS Mantra - Product Status
Table 30: LOTUS Mantra - Product Description
Table 31: Lotus Valve System - 21 mm - Product Status
Table 32: Lotus Valve System - 21 mm - Product Description
Table 33: Lotus Valve System - 23 mm - Product Status
Table 34: Lotus Valve System - 23 mm - Product Description
Table 35: Lotus Valve System - 25 mm - Product Status
Table 36: Lotus Valve System - 25 mm - Product Description
Table 37: Lotus Valve System - 27 mm - Product Status
Table 38: Lotus Valve System - 27 mm - Product Description
Table 39: Lotus Valve System - 29 mm - Product Status
Table 40: Lotus Valve System - 29 mm - Product Description
Table 41: Boston Scientific Corp - Ongoing Clinical Trials Overview

List of Figures
Figure 1: Transcatheter Aortic Valve Implantation (TAVI) - Pipeline Products by Stage of Development
Figure 2: Transcatheter Aortic Valve Implantation (TAVI) - Pipeline Products by Territory
Figure 3: Transcatheter Aortic Valve Implantation (TAVI) - Pipeline Products by Regulatory Path
Figure 4: Transcatheter Aortic Valve Implantation (TAVI) - Pipeline Products by Estimated Approval Date
Figure 5: Transcatheter Aortic Valve Implantation (TAVI) - Ongoing Clinical Trials
Note: Product cover images may vary from those shown
  • Aegis Surgical Limited
  • Anteris Technologies Ltd
  • AorTx, Inc.
  • Arbor Surgical Technologies, Inc.
  • Boston Scientific Corp
  • Carena Healthcare Ltd
  • Clemson University
  • Colibri Heart Valve LLC
  • Daidalos Solutions BV
  • Direct Flow Medical Inc (Inactive)
  • DSM Dyneema BV
  • Dura LLC
  • Edwards Lifesciences Corp
  • Foldax Inc
  • HLT, Inc.
  • JC Medical, Inc.
  • JenaValve Technology GmbH
  • Mayo Clinic
  • Medtronic Plc
  • MicroPort Scientific Corp
  • NVT AG
  • Peijia Medical Ltd
  • PolyNova Cardiovascular Inc
  • RegenaGraft
  • ReValve Med Inc
  • SAS Cormove
  • St. Jude Medical LLC
  • Stony Brook University
  • Symetis SA
  • The University of British Columbia
  • Thubrikar Aortic Valve, Inc.
  • University College London
  • University of California San Francisco
  • University of Cambridge
  • University of Iowa
  • Vascular Concepts Ltd
  • Venus MedTech
  • Xeltis AG
Note: Product cover images may vary from those shown
Adroll
adroll